Concepedia

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

Otylia Kowal‐Bielecka, Robert Landewé, Jérôme Avouac, Sylwia Chwieśko, Irene Miniati, László Czirják, Philip J. Clements, Chris Denton, Dominique Farge, Kim Fligelstone,

Annals of the Rheumatic Diseases · 2009 · 617 citations · 70 references

DOIFull text

Open access

Concepts

References

70

Bosentan Therapy for Pulmonary Arterial Hypertension

Lewis J. Rubin, David B. Badesch, Robyn J. Barst et al. · New England Journal of Medicine · 2002 · 2.7K citations · Full text

, , +17

Inhaled Iloprost for Severe Pulmonary Hypertension

Horst Olschewski, Gérald Simonneau, Nazzareno Galiè et al. · New England Journal of Medicine · 2002 · 1.8K citations · Full text

, , +12

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

, , +10

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick, G Simonneau, Olivier Sitbon et al. · The Lancet · 2001 · 1.5K citations

, , +13

Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial

Gérald Simonneau, Robyn J. Barst, Nazzareno Galiè et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 1.4K citations

, , +11